Studies have shown that active fund managers routinely underperform the S&P500 index*​

SkinHealth Systems Inc. (NASDAQ: SKIN)

SKIN Stock Predictions and Ratings

WSX Rating:
SELL
WSX Forecast (1yr):
-0.60%
Analyst Rating:
BUY
Analyst Forecast (1yr):
20.70%

SKIN Stock Analysis

SKIN PE Ratio:

SKIN PEG Ratio: Not Available

SKIN Forward EPS Growth (12 month): 0.00%

SKIN PS Ratio: 0.3

SKIN PSG Ratio: 0.1

SKIN Forward Revenue Growth (12 month): 4.90%

SKIN Articles

No data was found